MLMIB Stock Overview
Metrics in Balance N.V. owns and operates healthcare clinics in the Netherlands.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Metrics in Balance N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.075 |
| 52 Week High | €0.32 |
| 52 Week Low | €0.043 |
| Beta | 0.27 |
| 1 Month Change | 68.54% |
| 3 Month Change | -58.33% |
| 1 Year Change | n/a |
| 3 Year Change | -97.07% |
| 5 Year Change | n/a |
| Change since IPO | -98.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| MLMIB | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.2% |
| 1Y | n/a | 11.5% | 4.0% |
Return vs Industry: Insufficient data to determine how MLMIB performed against the French Medical Equipment industry.
Return vs Market: Insufficient data to determine how MLMIB performed against the French Market.
Price Volatility
| MLMIB volatility | |
|---|---|
| MLMIB Average Weekly Movement | 31.9% |
| Medical Equipment Industry Average Movement | 5.7% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.3% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: MLMIB's share price has been volatile over the past 3 months.
Volatility Over Time: MLMIB's weekly volatility has increased from 18% to 32% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | Dirk Verstraete | metricsinbalance.com |
Metrics in Balance N.V. owns and operates healthcare clinics in the Netherlands. The company offers chiropractic care and physical therapy, lifestyle testing, and occluso-posture therapy services. Metrics in Balance N.V. was incorporated in 2016 and is based in Gent, Belgium.
Metrics in Balance N.V. Fundamentals Summary
| MLMIB fundamental statistics | |
|---|---|
| Market cap | €329.29k |
| Earnings (TTM) | -€53.46k |
| Revenue (TTM) | €300.00 |
1,098x
P/S Ratio-6.2x
P/E RatioIs MLMIB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLMIB income statement (TTM) | |
|---|---|
| Revenue | €300.00 |
| Cost of Revenue | €56.75k |
| Gross Profit | -€56.45k |
| Other Expenses | -€2.99k |
| Earnings | -€53.46k |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.012 |
| Gross Margin | -18,817.00% |
| Net Profit Margin | -17,819.67% |
| Debt/Equity Ratio | 2.0% |
How did MLMIB perform over the long term?
See historical performance and comparison